FindTrial
Sign In

Effects of cardiac autonomic nerve modification on sinus bradycardia

Effects of cardiac autonomic nerve modification on sinus bradycardia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019365
Enrollment
Unknown
Registered
2018-11-07
Start date
2017-01-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinus Bradycardia

Interventions

Elderly Group:cardiac autonomic nerve modification
Non-elderly Group:cardiac autonomic nerve modification
Control Group:None

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with dizziness, fatigue or palpitation and diagnosed with sinus bradycardia by a EKG or Holter

Exclusion criteria

Exclusion criteria: Patients were excluded if they had drug-induced SB, sinus pause >2.0 s, positive atropine test, corrected sinus node recovery time (cSNRT) >525 ms. A positive atropine test was defined as SR <90 beats/min within 20 min, junctional rhythm, or sinus pause after intravenous administration of 0.03 mg/kg atropine.

Design outcomes

Primary

MeasureTime frame
heart rate;Heart rate variability;—

Countries

China

Contacts

Public ContactZhang Yu

Shanghai Chest Hospital

zy313xnlb@163.com+86 18621505189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026